Review/Regulation
Photogallery: Asia Risk Congress 2015
Free-to-view photographs from the Asia Risk Congress 2015
Basel II and Basel III: Top articles from Risk.net
The ink was hardly dry on Basel II when the international financial crisis saw that agreement being ripped up and recreated as Basel III.
Derivatives clearing: a selection of coverage from Risk.net
Derivatives clearing is one of the hottest regulatory topics at the moment around the world.
Nordic horizons
Markets in the Nordic region have been far from immune from the troubles that have hit structured products across Europe. But speakers and delegates at the Structured Products Nordic Region conference spoke of light on the horizon - despite the pressing…
Product reviews by Future Value Consultants
Product Reviews
US stock pick
Product Reviews
Buying in a flat market
Credit Suisse has launched buffered accelerated return equity securities linked to the S&P 500 index, in which participation can be as high as 500%, subject to a 20% maximum return in addition to principal
Heineken
Our regular look at groundbreaking and innovative deals in the primary markets takes in the £400 million unrated Heineken deal, and BP's monster $3.25 billion offering
Product reviews by Future Value Consultants
Product reviews
Blue Sky bank play
Product Review
Banks with caps
Product Review
Before the buffer
Product Review
Product reviews by Future Value Consultants
Product reviews
Roche
An in-depth look at the primary market's most innovative transactions. This month: the $16bn deal from Swiss pharma firm Roche, and Westpac's yen issue
Cliquet deposit
Product Review
Product reviews by Future Value Consultants
Product reviews
Deals of the Month: GDF Suez
The primary markets have been buzzing since the start of the year. We profile GDF Suez's mammoth EUR4.25bn deal, the $1.5bn five-year from Staples, and Toyota's Swiss franc issue